Open Medicine
(May 2024)
Efficacy of tacrolimus monotherapy in primary membranous nephropathy
Zhang Ya-pu,
Ran Lei,
Guo Li,
Gou Yan-Li,
Guo Shan-shan,
Xu Yang,
Hua Xin,
Chen Hang
Affiliations
Zhang Ya-pu
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Ran Lei
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Guo Li
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Gou Yan-Li
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Guo Shan-shan
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Xu Yang
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
Hua Xin
The Sixth Medical Center of Pla General Hospital, Haidian District, Beijing, China
Chen Hang
Department of Nephrology, Affiliated Hospital of Hebei University, Lianchi District, Baoding, 071000, Hebei, China
DOI
https://doi.org/10.1515/med-2024-0957
Journal volume & issue
Vol. 19,
no. 1
Abstract
Read online
The aim of this study was to observe the remission of primary membranous nephropathy (PMN) and evaluate the efficacy of tacrolimus (TAC) monotherapy for PMN in comparison with TAC combined with a low-dose glucocorticoid (GC) protocol (TAC + GC).
Keywords
WeChat QR code
Close
